NasdaqGM - Delayed Quote USD
Arcturus Therapeutics Holdings Inc. (ARCT)
12.65
+0.48
+(3.94%)
At close: April 23 at 4:00:00 PM EDT
12.62
-0.03
(-0.24%)
Pre-Market: 9:20:35 AM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-59,747
-59,747
-18,099
31,993
-135,043
Investing Cash Flow
-648
-648
-2,901
-7,726
-3,406
Financing Cash Flow
5,418
5,418
-24,087
-2,859
48,016
End Cash Position
293,913
293,913
348,890
393,977
372,569
Income Tax Paid Supplemental Data
1,407
1,407
--
--
--
Interest Paid Supplemental Data
--
--
2,127
813
684
Capital Expenditure
-648
-648
-2,901
-7,726
-3,406
Issuance of Capital Stock
682
682
609
411
515
Issuance of Debt
--
--
20,000
--
46,599
Repayment of Debt
--
--
-47,364
-5,000
--
Free Cash Flow
-60,395
-60,395
-21,000
24,267
-138,449
12/31/2021 - 5/22/2013
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EDIT Editas Medicine, Inc.
1.5600
0.00%
PHAT Phathom Pharmaceuticals, Inc.
4.0200
+1.52%
VIR Vir Biotechnology, Inc.
5.97
+2.93%
IMVT Immunovant, Inc.
14.45
+1.40%
NTLA Intellia Therapeutics, Inc.
8.09
-2.65%
DNLI Denali Therapeutics Inc.
14.87
+1.85%
RARE Ultragenyx Pharmaceutical Inc.
37.31
+3.90%
CAPR Capricor Therapeutics, Inc.
13.15
-5.33%
CVAC CureVac N.V.
3.1700
-0.63%
OCUL Ocular Therapeutix, Inc.
7.85
-0.76%